Results for “Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Rapid Quantitative Test”

Name, manufacturer or identifier

Manufacturer (optional)

Filters

Registry EUDAMED 2 FDA 510(k) incl. De Novo FDA PMA GUDID

Country / market European Union (all) 2

More countries (1)

Italy 2

Risk class Class I Class IIa Class IIb Class III Class II (US)

More classes (11)

Class A Class B Class C Class D IVD General 2 IVD Annex II List A IVD Annex II List B IVD for self-testing Active implantable (AIMDD) Unclassified (FDA) Not classified (FDA)

Verified Verified only

Category (EMDN)

Browse by category

2 devices foundsorted by relevance

Clear all

DeviceDevice · Manufacturer · Authorizations Verified

Status

Regime

Registry

Class

Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) Rapid Quantitative Test

Xenta Biomedical Science Co., Ltd.,China Group of variants

Active Regimes: CE IVDD Registry: EUDAMED Class:IVD General

Previous Next

Showing 1-2 of 2

deviCERTS Global Medical Device Regulatory Database

About [email protected]